Iron, oxygen, and the pulmonary circulation.

Area of Science:

• Pulmonary Medicine
• Cardiovascular Physiology
• Molecular Biology

Background:

• Hypoxic pulmonary vasoconstriction (HPV) is a physiological response to low alveolar oxygen.
• The hypoxia-inducible factor (HIF) pathway plays a critical role in regulating HPV.
• HIF pathway activity is sensitive to intracellular iron availability, acting as an oxygen and iron sensor.

Purpose of the Study:

• To review the temporal phases of HPV.
• To explore the role of the HIF pathway and its oxygen/iron-sensing mechanisms in HPV.
• To examine the clinical relevance of iron status in HPV-related conditions.

Main Methods:

• Review of existing literature on HPV, HIF pathway, and iron metabolism.
• Analysis of human studies on iron chelation and supplementation.
• Exploration of iron's role in high-altitude illness and chronic cardiopulmonary disease.

Main Results:

• HPV occurs in distinct temporal phases.
• HIF-hydroxylase enzymes, sensitive to iron, are key oxygen sensors in the HIF pathway.
• Human studies confirm the in vitro-observed iron sensitivity of the HIF pathway is relevant to pulmonary vascular physiology.
• Iron status is significant in high-altitude illness and chronic cardiopulmonary disease.

Conclusions:

• The HIF pathway's iron sensitivity is crucial for human pulmonary vascular function.
• Iron status is a critical factor in managing high-altitude illness and chronic cardiopulmonary disease.
• Intravenous iron may hold therapeutic potential for these conditions, warranting further investigation into complex iron-sensing interactions.